Bain Capital Life Sciences Investors, LLC — Form 4 insider transactions

Bain Capital Life Sciences Investors, LLC — Full 13F portfolio →

Buys and sells reported on SEC Form 4 — filed within two business days of each trade when a filer's ownership in a stock crosses 10%. This is the fastest public window into what the manager is doing.

Transaction date Activity Security Shares Price Total Filing
2026-04-30 Sell Heartflow, Inc. 56,224 $30.05 $1,689,531 SEC filing
2026-04-30 Sell Heartflow, Inc. 892,533 $29.18 $26,044,113 SEC filing
2026-04-29 Sell Heartflow, Inc. 797,133 $29.37 $23,411,796 SEC filing
2026-04-28 Sell Heartflow, Inc. 254,110 $30.51 $7,752,896 SEC filing
2026-04-20 Buy Kailera Therapeutics, Inc. 1,562,500 $16.00 $25,000,000 SEC filing
2026-04-20 Conversion Kailera Therapeutics, Inc. 4,145,768 — — SEC filing
2026-04-20 Conversion Kailera Therapeutics, Inc. 16,875,000 — — SEC filing

How Form 4 differs from 13F

13F filings are quarterly snapshots, up to 45 days late. Form 4 is transaction-level and lands within two business days — but only covers stocks where the filer reports beneficial ownership above 10%. Pair the two: 13F for the whole portfolio, Form 4 for what the largest holders are doing right now.

All insider transactions →